Points of undenatured type II collagen application in musculoskeletal pain syndromes treatment-Reference-Cited by-同舟云学术

Points of undenatured type II collagen application in musculoskeletal pain syndromes treatment

Published:2022 Issue:11 Volume:122 Page:40
ISSN:1997-7298
Container-title:Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova
language:en
Short-container-title:Z. nevrol. psikhiatr. im. S.S. Korsakova

Author:

Shavlovskaya O.A.^ORCID,Gromova O.A.^ORCID,Torshin I.Yu.^ORCID

Publisher

Media Sphere Publishing Group

Subject

Psychiatry and Mental health,Neurology (clinical)

Reference24 articles.

1. Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the “Magenta osteoarthritis study”

2. Facet joint osteoarthritis as a component of non-specific low back pain

3. Bagchi D, Misner B, Bagchi M, et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. Int J Clin Pharmacol Res. 2002;22(3-4):101-110

4. Oral tolerance

5. Molecular Mechanisms of Action of Undenatured Type II Collagen: Experimental and Clinical Evidence

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Admitting a patient with musculoskeletal pain following COVID-19 disease;Neurology, Neuropsychiatry, Psychosomatics;2023-12-17

2. Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-10-10

3. Computational linguistics and sentiment analysis of misconceptions in pharmacotherapy of osteoarthritis pain;Epilepsy and paroxysmal conditions;2023-09-28

4. Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity;Neurology, Neuropsychiatry, Psychosomatics;2023-08-15

5. From misconceptions to reasonable osteoarthritis patients therapy;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2023-06-07